Literature DB >> 15579134

A novel site contributing to growth-arrest-specific gene 6 binding to its receptors as revealed by a human monoclonal antibody.

Paul W Fisher1, Michael Brigham-Burke, Sheng-Jiun Wu, Jinquan Luo, Jill Carton, Kim Staquet, Wei Gao, Sheila Jackson, Deidra Bethea, Cailin Chen, Bing Hu, Jill Giles-Komar, Jing Yang.   

Abstract

Gas6 (growth-arrest-specific gene 6) is a vitamin K-dependent protein known to activate the Axl family of receptor tyrosine kinases. It is an important regulator of thrombosis and many other biological functions. The C-terminus of Gas6 binds to receptors and consists of two laminin-like globular domains LG1 and LG2. It has been reported that a Ca2+-binding site at the junction of LG1 and LG2 domains and a hydrophobic patch at the LG2 domain are important for receptor binding [Sasaki, Knyazev, Cheburkin, Gohring, Tisi, Ullrich, Timpl and Hohenester (2002) J. Biol. Chem. 277, 44164-44170]. In the present study, we developed a neutralizing human monoclonal antibody, named CNTO300, for Gas6. The antibody was generated by immunization of human IgG-expressing transgenic mice with recombinant human Gas6 protein and the anti-Gas6 IgG sequences were rescued from an unstable hybridoma clone. Binding of Gas6 to its receptors was partially inhibited by the CNTO300 antibody in a dose-dependent manner. To characterize further the interaction between Gas6 and this antibody, the binding kinetics of CNTO300 for recombinant Gas6 were compared with independently expressed LG1 and LG2. The CNTO300 antibody showed comparable binding affinity, yet different dependence on Ca2+, to Gas6 and LG1. No binding to LG2 was detected. In the presence of EDTA, binding of the antibody to Gas6 was disrupted, but no significant effect of EDTA on LG1 binding was evident. Further epitope mapping identified a Gas6 peptide sequence recognized by the CNTO300 antibody. This peptide sequence was found to be located at the LG1 domain distant from the Ca2+-binding site and the hydrophobic patch. Co-interaction of Gas6 with its receptor and CNTO300 antibody was detected by BIAcore analysis, suggesting a second receptor-binding site on the LG1 domain. This hypothesis was further supported by direct binding of Gas6 receptors to an independently expressed LG1 domain. Our results revealed, for the first time, a second binding site for Gas6-receptor interaction.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15579134      PMCID: PMC1135003          DOI: 10.1042/BJ20040859

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  48 in total

Review 1.  The Gas6/Axl system: a novel regulator of vascular cell function.

Authors:  M G Melaragno; Y W Fridell; B C Berk
Journal:  Trends Cardiovasc Med       Date:  1999-11       Impact factor: 6.677

2.  Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro 3 family.

Authors:  Q Lu; G Lemke
Journal:  Science       Date:  2001-07-13       Impact factor: 47.728

3.  Tyro-3 family receptors are essential regulators of mammalian spermatogenesis.

Authors:  Q Lu; M Gore; Q Zhang; T Camenisch; S Boast; F Casagranda; C Lai; M K Skinner; R Klein; G K Matsushima; H S Earp; S P Goff; G Lemke
Journal:  Nature       Date:  1999-04-22       Impact factor: 49.962

4.  Generating high-avidity human Mabs in mice.

Authors:  M Neuberger
Journal:  Nat Biotechnol       Date:  1996-07       Impact factor: 54.908

5.  GAS6 induces Axl-mediated chemotaxis of vascular smooth muscle cells.

Authors:  Y W Fridell; J Villa; E C Attar; E T Liu
Journal:  J Biol Chem       Date:  1998-03-20       Impact factor: 5.157

6.  Release of a product of growth arrest-specific gene 6 from rat platelets.

Authors:  Y Ishimoto; T Nakano
Journal:  FEBS Lett       Date:  2000-01-21       Impact factor: 4.124

7.  Expression of receptor tyrosine kinase Axl and its ligand Gas6 in rheumatoid arthritis: evidence for a novel endothelial cell survival pathway.

Authors:  K O'Donnell; I C Harkes; L Dougherty; I P Wicks
Journal:  Am J Pathol       Date:  1999-04       Impact factor: 4.307

8.  Gas6, a ligand for the receptor protein-tyrosine kinase Tyro-3, is widely expressed in the central nervous system.

Authors:  A L Prieto; J L Weber; S Tracy; M J Heeb; C Lai
Journal:  Brain Res       Date:  1999-01-23       Impact factor: 3.252

9.  Increased expression of Axl tyrosine kinase after vascular injury and regulation by G protein-coupled receptor agonists in rats.

Authors:  M G Melaragno; D A Wuthrich; V Poppa; D Gill; V Lindner; B C Berk; M A Corson
Journal:  Circ Res       Date:  1998-10-05       Impact factor: 17.367

10.  High-avidity human IgG kappa monoclonal antibodies from a novel strain of minilocus transgenic mice.

Authors:  D M Fishwild; S L O'Donnell; T Bengoechea; D V Hudson; F Harding; S L Bernhard; D Jones; R M Kay; K M Higgins; S R Schramm; N Lonberg
Journal:  Nat Biotechnol       Date:  1996-07       Impact factor: 54.908

View more
  15 in total

1.  Structural basis for Gas6-Axl signalling.

Authors:  Takako Sasaki; Pjotr G Knyazev; Naomi J Clout; Yuri Cheburkin; Walter Göhring; Axel Ullrich; Rupert Timpl; Erhard Hohenester
Journal:  EMBO J       Date:  2005-12-15       Impact factor: 11.598

2.  Axl receptor blockade ameliorates pulmonary pathology resulting from primary viral infection and viral exacerbation of asthma.

Authors:  Takehiko Shibata; David M Habiel; Ana L Coelho; Steven L Kunkel; Nicholas W Lukacs; Cory M Hogaboam
Journal:  J Immunol       Date:  2014-03-21       Impact factor: 5.422

3.  Respiratory syncytial virus infection exacerbates pneumococcal pneumonia via Gas6/Axl-mediated macrophage polarization.

Authors:  Takehiko Shibata; Airi Makino; Ruiko Ogata; Shigeki Nakamura; Toshihiro Ito; Kisaburo Nagata; Yoshihiko Terauchi; Taku Oishi; Mikiya Fujieda; Yoshimasa Takahashi; Manabu Ato
Journal:  J Clin Invest       Date:  2020-06-01       Impact factor: 14.808

4.  Tyro3 carboxyl terminal region confers stability and contains the autophosphorylation sites.

Authors:  Hanshuang Shao; Douglas Lauffenburger; Alan Wells
Journal:  Biochem Biophys Res Commun       Date:  2017-06-28       Impact factor: 3.575

5.  3D-QSAR modeling and molecular docking study on Mer kinase inhibitors of pyridine-substituted pyrimidines.

Authors:  Zhuang Yu; Xianchao Li; Cuizhu Ge; Hongzong Si; Lianhua Cui; Hua Gao; Yunbo Duan; Honglin Zhai
Journal:  Mol Divers       Date:  2014-10-30       Impact factor: 2.943

6.  A critical role of Gas6/Axl signal in allergic airway responses during RSV vaccine-enhanced disease.

Authors:  Takehiko Shibata; Manabu Ato
Journal:  Immunol Cell Biol       Date:  2017-07-19       Impact factor: 5.126

7.  Role of growth arrest-specific gene 6 in the development of fungal allergic airway disease in mice.

Authors:  Takehiko Shibata; Ugur Burcin Ismailoglu; Nicolai A Kittan; Ana Paula Moreira; Ana Lucia Coelho; Geoffrey L Chupp; Steven L Kunkel; Nicholas W Lukacs; Cory M Hogaboam
Journal:  Am J Respir Cell Mol Biol       Date:  2014-11       Impact factor: 6.914

Review 8.  TAM receptor tyrosine kinases: biologic functions, signaling, and potential therapeutic targeting in human cancer.

Authors:  Rachel M A Linger; Amy K Keating; H Shelton Earp; Douglas K Graham
Journal:  Adv Cancer Res       Date:  2008       Impact factor: 6.242

9.  The Mer receptor tyrosine kinase is expressed on discrete macrophage subpopulations and mainly uses Gas6 as its ligand for uptake of apoptotic cells.

Authors:  Wen-Hai Shao; Yuxuan Zhen; Robert A Eisenberg; Philip L Cohen
Journal:  Clin Immunol       Date:  2009-07-24       Impact factor: 3.969

10.  An engineered Axl 'decoy receptor' effectively silences the Gas6-Axl signaling axis.

Authors:  Mihalis S Kariolis; Yu Rebecca Miao; Douglas S Jones; Shiven Kapur; Irimpan I Mathews; Amato J Giaccia; Jennifer R Cochran
Journal:  Nat Chem Biol       Date:  2014-09-21       Impact factor: 15.040

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.